Armed with what CEO Robert Davis called the “broadest and widest pipeline we’ve had in years,” Merck is preparing for its ...
Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and AI systems help design new drug mole ...
PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...
Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...
Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...
HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...
WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...
The integration of cannabinoids into mainstream pharmaceutical practices has been a topic of significant debate and interest over the past decade. As scientific research continues to unravel the ...
Africa's health future hinges on its ability to finance and commercialize its own medical innovations, rather than rely on increasingly uncertain international funding, African science leaders have ...
4 analysts have shared their evaluations of Collegium Pharmaceutical (NASDAQ:COLL) during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find ...
LITTLETON, Colo. and CHICAGO, June 3, 2025 /PRNewswire/ -- DeFloria, Inc., the botanical-drug developer advancing the first of its kind AJA001 oral solution for autism spectrum disorder (ASD), today ...
In the preceding three months, 27 analysts have released ratings for Biomarin Pharmaceutical (NASDAQ:BMRN), presenting a wide array of perspectives from bullish to bearish. In the table below, you'll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results